
T2 Biosystems TTOO
Quartalsbericht 2024-Q3
hinzugefügt 14.11.2024
T2 Biosystems EV/EBITDA 2011-2026 | TTOO
EV/EBITDA Jährlich T2 Biosystems
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.533 | -9.28 | -1.58 | -3.03 | -3.13 | -2.27 | -3.31 | -4.49 | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 0.533 | -9.28 | -3.32 |
EV/EBITDA anderer Aktien in der Diagnostik & Forschung
| Name | EV/EBITDA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Akumin
AKU
|
28.1 | - | -17.87 % | $ 25.9 M | ||
|
Centogene N.V.
CNTG
|
0.387 | - | -6.23 % | $ 30.6 M | ||
|
Agilent Technologies
A
|
27.4 | $ 115.62 | 0.06 % | $ 35.1 B | ||
|
Accelerate Diagnostics
AXDX
|
-5.56 | - | -61.36 % | $ 2.46 M | ||
|
Chembio Diagnostics
CEMI
|
-1.23 | - | 0.22 % | $ 16.8 M | ||
|
Co-Diagnostics
CODX
|
3.62 | $ 1.65 | -1.2 % | $ 2.19 M | ||
|
Aspira Women's Health
AWH
|
-2.63 | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
-26.9 | - | -13.05 % | $ 7.29 M | ||
|
Castle Biosciences
CSTL
|
-21.2 | $ 24.98 | 2.13 % | $ 694 M | ||
|
Check-Cap Ltd.
CHEK
|
-0.674 | - | - | $ 9.42 M | ||
|
Enzo Biochem
ENZ
|
58.3 | - | -8.98 % | $ 14.8 K | ||
|
CareDx, Inc
CDNA
|
-100 | $ 21.85 | 2.92 % | $ 1.16 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
-73.4 | - | - | $ 562 M | ||
|
DermTech
DMTK
|
-2.44 | - | -11.32 % | $ 2.94 M | ||
|
Exact Sciences Corporation
EXAS
|
-20.8 | - | - | $ 19.8 B | ||
|
Fulgent Genetics
FLGT
|
2.58 | $ 15.6 | -4.35 % | $ 472 M | ||
|
HTG Molecular Diagnostics
HTGM
|
-1.42 | - | -20.0 % | $ 1.06 M | ||
|
Global Cord Blood Corporation
CO
|
-3.52 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-13.6 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-2.67 | - | - | $ 7.1 B | ||
|
Illumina
ILMN
|
70.5 | $ 128.52 | 0.5 % | $ 20.4 B | ||
|
Genetron Holdings Limited
GTH
|
-2.67 | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
22 | $ 171.23 | 0.86 % | $ 8.49 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
20.8 | - | - | $ 10.7 B | ||
|
Guardant Health
GH
|
-28.8 | $ 88.5 | -0.46 % | $ 11.1 B | ||
|
Koninklijke Philips N.V.
PHG
|
55.6 | $ 27.54 | 0.25 % | $ 20 B | ||
|
Heska Corporation
HSKA
|
141 | - | - | $ 1.31 B | ||
|
Interpace Biosciences
IDXG
|
-6.02 | $ 1.93 | -2.08 % | $ 8.54 M | ||
|
Lantheus Holdings
LNTH
|
-187 | $ 84.11 | -0.26 % | $ 5.68 B | ||
|
Medpace Holdings
MEDP
|
30.7 | $ 421.37 | 2.64 % | $ 12.2 B | ||
|
QIAGEN N.V.
QGEN
|
13.2 | - | - | $ 10.6 B | ||
|
Motus GI Holdings
MOTS
|
0.351 | - | -34.28 % | $ 263 K | ||
|
Biomerica
BMRA
|
-6.24 | $ 2.18 | 1.87 % | $ 5.01 M | ||
|
ICON Public Limited Company
ICLR
|
38 | $ 103.21 | 1.02 % | $ 8.51 B | ||
|
Laboratory Corporation of America Holdings
LH
|
8.7 | $ 263.43 | -0.12 % | $ 21.9 B | ||
|
Neogen Corporation
NEOG
|
40.3 | $ 9.45 | -0.94 % | $ 2.05 B | ||
|
Celcuity
CELC
|
-2.38 | $ 125.68 | 3.84 % | $ 5.88 B | ||
|
NeoGenomics
NEO
|
-33.5 | $ 8.61 | 3.86 % | $ 1.1 B | ||
|
National Research Corporation
NRC
|
21 | $ 17.11 | -0.7 % | $ 383 M | ||
|
Myriad Genetics
MYGN
|
-17.2 | $ 4.83 | 1.05 % | $ 447 M | ||
|
Natera
NTRA
|
-19.5 | $ 204.39 | 0.31 % | $ 20.1 B | ||
|
Quest Diagnostics Incorporated
DGX
|
5.51 | $ 196.63 | 0.21 % | $ 21.8 B | ||
|
Invitae Corporation
NVTA
|
-10.7 | - | - | $ 21.2 M | ||
|
OpGen
OPGN
|
0.274 | - | -16.95 % | $ 1.54 M | ||
|
PerkinElmer
PKI
|
18.8 | - | -0.91 % | $ 14.7 B | ||
|
Organovo Holdings
ONVO
|
0.992 | - | -2.3 % | $ 19.4 M | ||
|
Precipio
PRPO
|
-1.8 | - | - | $ 49.3 M | ||
|
Personalis
PSNL
|
-7.07 | $ 5.96 | -2.3 % | $ 353 M | ||
|
Senseonics Holdings
SENS
|
-13.8 | $ 7.27 | 3.12 % | $ 303 M | ||
|
Burning Rock Biotech Limited
BNR
|
-1.51 | $ 19.06 | -7.88 % | $ 205 M |